Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Birhiray, R"'
Autor:
Lownik J; Cedars Sinai Medical Center, Samuel Oschin Cancer Center, Los Angeles, California., Boiarsky J; UCLA, Santa Monica Cancer Care, Santa Monica, California., Birhiray R; Hematology Oncology of Indiana/American Oncology Network, Indianapolis, Indiana., Merchant A; Cedars Sinai Medical Center, Samuel Oschin Cancer Center, Los Angeles, California., Mead M; UCLA, Santa Monica Cancer Care, Santa Monica, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 2895-2904.
Poster-Abstract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=unidue___bib::3d0b82b90205c4bad7248e307779d79b
Autor:
Martin Jimenez, M., Gnant, M. I., Ejlertsen, B., Mansi, J. L., Ruiz-Borrego, M., Jakobsen, E. H., Osborne, C. K., Birhiray, R., Zhang, B., Wong, A., Moy, B., Holmes, F. A.
Publikováno v:
Martin Jimenez, M, Gnant, M I, Ejlertsen, B, Mansi, J L, Ruiz-Borrego, M, Jakobsen, E H, Osborne, C K, Birhiray, R, Zhang, B, Wong, A, Moy, B & Holmes, F A 2020, ' Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+HR+ breast cancer after trastuzumab-based therapy on patient outcomes ', Annals of Oncology, vol. 31, no. Suppl. 2, pp. S43 . https://doi.org/10.1016/j.annonc.2020.03.023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::5ebc1bd1ac8d2162930fa81beea411bc
https://portal.findresearcher.sdu.dk/da/publications/974bd07b-099e-4367-a8c4-acb67f76f02c
https://portal.findresearcher.sdu.dk/da/publications/974bd07b-099e-4367-a8c4-acb67f76f02c
Autor:
Rajan A; Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gray JE; Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Devarakonda S; Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Birhiray R; Medical Oncology, Investigative Clinical Research of Indiana, Indianapolis, Indiana, USA., Korchin B; Bavarian Nordic, Morrisville, North Carolina, USA., Menius E; Bavarian Nordic, Morrisville, North Carolina, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gulley JL; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Feb 01; Vol. 152 (3), pp. 447-457. Date of Electronic Publication: 2022 Sep 09.
Publikováno v:
Leukemia (08876924). May2002, Vol. 16 Issue 5, p861. 4p.
Autor:
Martin Jimenez, M., Gnant, M.I., Ejlertsen, B., Mansi, J.L., Ruiz-Borrego, M., Jakobsen, E.H., Osborne, C.K., Birhiray, R., Zhang, B., Wong, A., Moy, B., Holmes, F.A.
Publikováno v:
In Annals of Oncology May 2020 31 Supplement 2:S43-S43
Autor:
Malhotra, Jyoti1 (AUTHOR) jymalhotra@coh.org, Huang, Amy2 (AUTHOR) amhuang@uchc.edu, Amini, Arya3 (AUTHOR) aamini@coh.org, Lee, Percy3 (AUTHOR) percylee@coh.org
Publikováno v:
Cancers. Nov2024, Vol. 16 Issue 21, p3603. 12p.
Autor:
Rajan, A. 1, Gray, J.E. 2, Devarakonda, S. 3, Gurtler, J. 4, Birhiray, R. 5, Paschold, E. 6, Dasgupta, A. 7, Heery, C. 8, Pico-Navarro, C. 8, Piechatzek, M. 9, Wagner, E. 10, Menius, E. 11, Donahue, R.N. 12, Schlom, J. 13, Gulley, J.L. 14
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v493-v494
Autor:
Keating, MJ, Cazin, B, Coutré, S, Birhiray, R, Kovacsovics, T, Langer, W, Leber, B, Maughan, T, Rai, K, Tjønnfjord, G, Bekradda, M, Itzhaki, M, Hérait, P
Publikováno v:
Journal of Clinical Oncology. 20:205-213
PURPOSE: We conducted a retrospective analysis to evaluate the safety and efficacy of Campath-1H, an anti-CD52 humanized monoclonal antibody, in previously treated T-prolymphocytic leukemia (T-PLL) patients in a compassionate-use program. PATIENTS AN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807cb03b62ad5646cbb91d17978659e7
https://doi.org/10.1200/jco.2002.20.1.205
https://doi.org/10.1200/jco.2002.20.1.205
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.